论文部分内容阅读
目的探讨小儿咳嗽变异性哮喘运用布地奈德联合孟鲁司特治疗的临床疗效。方法从收治的咳嗽变异性哮喘儿童患者中随机选取92例作为研究对象,随机分为布地奈德组(46例)与联合组(46例)。布地奈德组进行常规治疗的同时使用布地奈德气雾剂,联合组在布地奈德组的基础上结合孟鲁司特进行治疗,对两组所取得的疗效以及患者满意度进行对比分析。结果联合组患者满意度优于布地奈德组,联合组所取得的疗效也明显优于布地奈德组,结果具有统计学意义(P<0.05)。结论布地奈德与孟鲁司特联合使用治疗小儿咳嗽变异性哮喘疗效显著,且无不良反应情况的发生,患者恢复快,提高了患者的满意度。
Objective To investigate the clinical efficacy of budesonide combined with montelukast in children with cough variant asthma. Methods Ninety-two children with cough-variant asthma admitted to our hospital were selected randomly and randomly divided into the budesonide group (n = 46) and the combination group (n = 46). The budesonide group was treated with budesonide aerosol while conventional treatment. The combination group was treated with montelukast on the basis of budesonide group, and the curative effect and patient satisfaction were compared between the two groups. Results The patients in the combined group were better than the budesonide group in the degree of satisfaction. The curative effect in the combined group was also significantly better than that in the budesonide group. The result was statistically significant (P <0.05). Conclusions The combination of budesonide and montelukast is effective in treating children with cough variant asthma and has no adverse reactions. Patients recover quickly and improve patient satisfaction.